Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

WEAV earnings analysis

Filed May 5, 2026 · Our reading of the company's report

The latest report

Weave Communications reported a strong Q1 2026, with revenues reaching $65.5 million, a 17% increase year-over-year, and an EPS of $0.03, exceeding expectations by $0.05. The company continues to expand its footprint in…

Read full summary

Weave Communications reported a strong Q1 2026, with revenues reaching $65.5 million, a 17% increase year-over-year, and an EPS of $0.03, exceeding expectations by $0.05. The company continues to expand its footprint in the SMB healthcare sector while facing challenges regarding cash flow and operational efficiency. Despite ongoing losses, the positive revenue trend bolsters confidence for the upcoming quarters.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

73% Gross margin Operating margin Aug 2023 May 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Mar 2022 May 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$0.03
Gross margin
73%
Segment
Subscription and payment processing
Segment
Onboarding
Segment
Phone Hardware

What stood out

  • Revenue Growth of 17% Year-Over-Year

    Total revenues for Q1 2026 were $65.5 million, an increase of $9.7 million from $55.8 million in Q1 2025.

  • Positive Earnings Surprise

    Reported EPS of $0.03 exceeded the estimate of -$0.02 by $0.05, demonstrating improved profitability.

  • Improved Gross Margin

    Gross margin improved to 73% in Q1 2026 from 72% in Q1 2025, showcasing better cost efficiencies.

  • Increase in Recurring Revenues

    Recurring subscription and payment processing revenue accounted for 90% of total revenues, supporting stable cash flows.

  • Strong Demand for New Products

    New product offerings and enhanced functionalities have contributed to customer engagement and revenue growth.

  • Cash Reserves Available for Growth

    As of March 31, 2026, the company had $42.2 million in cash and short-term investments, providing a cushion for operational challenges.

What to watch

  • Negative Free Cash Flow

    Q1 2026 saw free cash flow of -$7.1 million compared to -$1.06 million in Q1 2025, indicating cash management issues.

  • Accumulated Losses

    The company reported an accumulated deficit of $324.8 million as of March 31, 2026, raising concerns over long-term profitability.

  • Customer Retention Risks

    Dollar-based net revenue retention rate dropped to 92% in Q1 2026 from 98% in Q1 2025, reflecting potential challenges in customer loyalty.

Management's outlook

Management expects Q2 2026 revenue to be between $67.2 million and $68.2 million.

Earlier filings 4

10-K · March 5, 2026

Weave positions itself as an AI-powered, vertical SaaS platform for SMB healthcare practices (dental, optometry, veterinary and specialty medical) with a unified communications, payments and AI workflow roadmap. Revenue…

10-K · March 13, 2025

Weave positions itself as an AI-enabled, all-in-one customer experience and payments platform purpose-built for small and medium-sized healthcare practices, integrating communications, scheduling and payments into a…

10-K · March 13, 2024

Weave positions itself as an all-in-one customer experience and payments platform for SMB healthcare practices, serving over 31,000 locations and more than 28,000 customers as of December 31, 2023. The 10-K emphasizes a…

10-Q · November 8, 2023

Weave reported Q3 revenue of $43,544,000, up $7,314,000 (20.2%) versus $36,230,000 in Q3 2022, with gross profit expanding to $29,935,000 (68.8% margin) and an operating loss that narrowed to $(8,022,000). Liquidity…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.